[1] FISHER E R,PALEKAR A S,REDMOND C,et al.Pathologic findings from the National Surgical Adjuvant Breast Project(protocol no.4)VI.invasive papillary cancer[J].Am J Clin pathol,1980,73(3):313-322.
[2] SIRIAUNKGUL S,TAVASSOLI F A.Invasive micropapillary carcinoma of breast.Mod Pathol,1993,6(6):660-662.
[3] 丁岚.乳腺浸润性微乳头状癌1例.诊断病理学杂志,2001,8(4):242.
[4] TAVASSOLI F A,DEVILEE P.WHO classification of tumours,pathology and genetics,tumours of the breast and female genital organs[M].Lyon:IARC Press,2003:35-36.
[5] 付丽,松山郁生,付笑影,等.乳腺浸润性微乳头状癌的形态改变与生物学行为的关系[J].中华病理学杂志,2004,33(1):21-25.
[6] 张燕娜,王常珺,周易冬,等.乳腺浸润性微乳头状癌与浸润性癌(非特殊型)腋窝淋巴结转移相关因素的病例对照研究[J].协和医学杂志,2015,6(3):166-172.
[7] GVNHAN-BLIGEN I,ZEKIOGLU O,USTVN E F,et al.Invasive micropapillary carcinoma of the breast:clinical,mammographic and sonographic findings with histopathologic correlation[J].Am J Roentgenol,2002,179(4):927-931.
[8] ACS G,PARAGH G,CHUANG S T,et al.The presence of micropapillary features and retraction artifact in core needle biopsy material predicts lymph node metastasis in breast carcinoma[J].Am J Surg Pathol,2009,33(2):202-210.
[9] CHEN A C,PAULINO A C,SCHWARTZ M R,et al.Prognostic markers for invasive micropapillary carcinoma of the breast:a population-based analysis[J].Clin Breast Cancer,2013,13(2):133-139.
[10] CHEN A C,PAULINO A C,SCHWARTZ M R,et al.Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast[J].Br J Cancer,2014,111(3):619-622.
[11] 梁月勉,王维娜.乳腺浸润性微乳头状癌与浸润性导管癌免疫组化及临床病理特征的比较[J].临床与实验病理学,2014,30(8):920-922.
[12] GOKCE H,DURAK M G,AKIN M M,et al.Invasive micropapillary carcinoma of the breast:a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma[J].Breast J,2013,19(4):374-381.
[13] GENTILE A,BEEETTE V.Invasive papillary and pseudopapillary(micropapillary)carcinoma of breast[J].Arch Anat Cytol Pathol,1996,44(5-6):225-230.
[14] TRESSERRA F,GRASES P J,FÁBREGAS R,et al.Invasive mieropapillary carcinoma. Distinct features of a poorly recognized variant of breast carcinoma[J].Eur J Gynaecol Oncol,1999,20(3):205-208.
[15] MIDDLETON L P,TRESSERA F,SOBEL M E,et al.Infiltrating micropapillary carcinoma of the breast[J].Mod Pathol,1999,12(5):499-504.
[16] 吴礼高,刘德纯.乳腺浸润性微乳头状癌研究进展[J].蚌埠医学院学报,2008,33(1):118-120.
[17] KHURANA K K,WILBUR D,DAWSON A E.Fine needle aspiration cytology of invasive micropapillary carcinoma of the breast.A report of two cases[J].Acta Cytol,1997, 41(4):1394-1398.
[18] SLAMON D J,CLARK G M,WONG S G,et al.Human breast cancer: corelation of relapse and survival with amplification of the HER-2/neu oncogene[J].Science,1987,235(4785):177-182.
[19] SCHONK D M,KUIJPERS H J,van DRUNEN E,et al.Assignment of the gene(s)involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10[J].Hum Genet,1989,83(3):297-299.
[20] YU J I,CHOI D H,PARK W,et al.Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast:matched case-control study[J].Breast,2010,19(3):231-237.
[21] 范宇,郎荣刚,王颖,等.乳腺浸润性微乳头状癌上皮性钙黏附素的表达及意义[J].中华病理学杂志,2004,33(4):308-310.
[22] PATERAKOS M,WATKIN W G,EDGETON S M,et al.Invasive micropapillary carcinoma of the breast:a prognostic study[J].Hum Pathol,1999,30(12):1459-1463.
[23] SHI W B,YANG L J,HU X.Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma:a population-based study from China[J].PLoS One,2014,9(6):e101390.
[24] CHEN H L,DING A.Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast. Breast,2015,24(6):723-731.
[25] 高小康,孙鹤庆.新辅助化疗对乳腺癌Cerb-B2表达的影响及其临床意义[J].现代医学,2013,41(11):787-791.
[26] PETTINATO G,MANIVEL C J,PANICO L,et al.Invasive micropapillary carcinoma of the breast:clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior[J].Am J Clin Pathol,2004,121(6):857-866.
[27] ALVARADO-CABRERO I,ALDERETE-VAZQUEZ G,QUINTAL-RAMIREZ M,et al.Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer:correlation of histology,hormone receptor status,Her2/Neu,and gross pathologic findings[J].Ann Diagn Pathol,2009,13(3):151-157.
[28] CHEN L,FAN Y,LANG R G,et al.Breast carcinoma with micropapillary features:clinicopathologic study and long-term follow-up of 100 cases[J].Int J Surg Pathol,2008,16(2):155-163.
[29] NIELSEN H M,OVERGAARD M,GRAU C,et al.Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy:long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies[J].J Clin Oncol,2006,24(15):2268-2275.
[30] RUGO H S.The importance of distant metastases in hormone-sensitive breast cancer[J].Breast,2008,17(Suppl.1):S3-S8.
[31] LOUIS-SYLVESTRE C,CLOUGH K,ASSELAIN B,et al.Axillary treatment in conservative management of operable breast cancer:dissection or radiotherapy?Results of a randomized study with 15 years of follow-up[J].J Clin Oncol,2004,22(1):97-101.
[32] RUDENSTAM C M,ZAHRIEH D,FORBES J F,et al.Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer:first results of International Breast Cancer Study Group Trial 10-93[J].J Clin Oncol,2006,24(3):337-344. |
